Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.05
+0.08 (1.61%)
Oct 19, 2026, 9:45 AM EDT - Market open
Journey Medical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Journey Medical stock has a consensus rating of "Strong Buy" and an average price target of $13.75. The average 1-year stock price forecast is 172.55% higher than the current stock price, while the lowest is $13 (+157.68%) and the highest is $15 (+197.32%).
Price Target: $13.75 (+172.55%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Journey Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $13 | Buy | Maintains | $13 | +157.68% | Sep 22, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +177.50% | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $13 | Buy | Maintains | $13 | +157.68% | May 14, 2026 |
Financial Forecast
Revenue This Year
80.08M
from 61.86M
Increased by 29.45%
Revenue Next Year
130.13M
from 80.08M
Increased by 62.50%
EPS This Year
n/a
EPS Next Year
n/a